去除凝血因子VIII单一位点N-连接聚糖可改变结构域特异性单克隆抗体的结合
本研究制备了四种去除单一位点N-连接聚糖的重组B结构域缺失型凝血因子VIII变体,评估其生化特性、小鼠骨髓来源树突状细胞的内吞作用及抗体反应。结果显示变体表达、活性和比活性降低,部分变体内吞减少,但免疫血友病A小鼠的抗体产生无差异,提示N-聚糖对抑制物形成无显著贡献。
要点
- 四种单一位点N-聚糖去除的凝血因子VIII变体表达、活性和比活性均降低。
- FVIII-N41G和FVIII-N1810A被小鼠骨髓来源树突状细胞内吞减少。
- 免疫血友病A小鼠中变体与BDD FVIII的抗体产生无差异。
核心结论
- 凝血因子VIII N-连接聚糖修饰可减少小鼠骨髓来源树突状细胞内吞及结构域特异性单克隆抗体结合,但未改变血友病A小鼠的从头抗体产生,提示N-聚糖对抑制物形成无显著贡献。
研究设计与样本
- 实验性研究:制备四种去除单一位点N-连接聚糖的重组B结构域缺失型凝血因子VIII变体(FVIII-N41G、FVIII-N239A、FVIII-N1810A、FVIII-N2118A),进行生化特性、小鼠骨髓来源树突状细胞内吞及免疫血友病A小鼠抗体反应评估。
主要发现
- 四种变体均确认去除了N-连接聚糖,糖基化谱与BDD FVIII相似。
- 变体与BDD FVIII相比,凝血酶激活或血管性血友病因子结合无差异,但所有变体表达、活性和比活性降低。
- FVIII-N41G和FVIII-N1810A被小鼠骨髓来源树突状细胞摄取减少。
- 免疫血友病A小鼠中变体与BDD FVIII的抗体发展无差异。
- 12种结构域特异性FVIII单克隆抗体中有一半对至少一种变体结合显著降低,A1结构域单克隆抗体2-116对FVIII-N239A的结合降低50%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A portion of individuals with hemophilia A develop neutralizing antibodies called inhibitors to glycoprotein factor VIII (FVIII). There are multiple risk factors that contribute to the risk of inhibitor formation. However, knowledge of the role of FVIII asparagine (N)-linked glycosylation in FVIII immunity is limited. OBJECTIVE: To evaluate the effect of site-specific N-linked glycan removal on FVIII biochemical properties, endocytosis by murine bone marrow-derived dendritic cells (BMDCs), and antibody responses. METHODS: Four recombinant B domain-deleted (BDD) FVIII variants with single-site amino acid substitutions to remove N-linked glycans were produced for experimental assays. RESULTS: BDD FVIII-N41G, FVIII-N239A, FVIII-N1810A, and FVIII-N2118A with confirmed removal of N-linked glycans and similar glycosylation profiles to BDD FVIII were produced. There were no differences in thrombin activation or von Willebrand factor binding of FVIII variants compared with BDD FVIII; however, reduced FVIII expression, activity, and specific activity was observed with all variants. BDD FVIII-N41G and FVIII-N1810A had reduced uptake by BMDCs, but there were no differences in antibody development in immunized hemophilia A mice compared with BDD FVIII. Half of a repertoire of 12 domain-specific FVIII MAbs had significantly reduced binding to ≥1 FVIII variant with a 50% decrease in A1 domain MAb 2-116 binding to FVIII-N239A. CONCLUSIONS: Modifications of FVIII N-linked glycans reduced FVIII endocytosis by BMDCs and binding of domain-specific FVIII MAbs, but did not alter de novo antibody production in hemophilia A mice, suggesting that N-glycans do not significantly contribute to inhibitor formation.
引用
- Ito J, Baldwin WH, Cox C, et al. Removal of single-site N-linked glycans on factor VIII alters binding of domain-specific monoclonal antibodies. J Thromb Haemost. 2021. PMID: 34863021. doi:10.1111/jth.15616
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。